Combined oral contraceptives: venous thrombosis [sounds like]
23 results
1 - 23
Combined oral contraceptives: venous thrombosis
Risk of venous thrombosis in users of 3rd vs. 2nd generation combined oral contraceptives - Hormonal contraception
- Oral contraceptives in patients who have experienced one venous thrombosis
- Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke
- Risk of venous thromboembolism in users of combined contraceptives
- Oral contraceptives in women with systemic lupus erythematosus
- Overweight in pregnancy
- Risk of thromboembolism in patients with COVID‐19 who are using hormonal contraception
- Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
- Hormonal contraception in overweight or obese women
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
- Polycystic ovary syndrome (PCOS)
- Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism
- Antenatal clinics: care and examinations